Your browser doesn't support javascript.
loading
Improved tumor control with antiangiogenic therapy after treatment with gemcitabine and nab-paclitaxel in pancreatic cancer.
Zhang, Zheng; Ji, Shunrong; Hu, Qiangsheng; Zhuo, Qifeng; Liu, Wei; Xu, Wenyan; Liu, Wensheng; Liu, Mengqi; Ye, Zeng; Fan, Guixiong; Xu, Xiaowu; Yu, Xianjun; Qin, Yi.
Afiliación
  • Zhang Z; Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Ji S; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Hu Q; Shanghai Pancreatic Cancer Institute, Shanghai, China.
  • Zhuo Q; Pancreatic Cancer Institute, Fudan University, Shanghai, China.
  • Liu W; Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Xu W; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Liu W; Shanghai Pancreatic Cancer Institute, Shanghai, China.
  • Liu M; Pancreatic Cancer Institute, Fudan University, Shanghai, China.
  • Ye Z; Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Fan G; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Xu X; Shanghai Pancreatic Cancer Institute, Shanghai, China.
  • Yu X; Pancreatic Cancer Institute, Fudan University, Shanghai, China.
  • Qin Y; Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Clin Transl Med ; 11(8): e398, 2021 08.
Article en En | MEDLINE | ID: mdl-34459132

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Adenocarcinoma / Carcinoma Ductal Pancreático / Bevacizumab / Antineoplásicos Inmunológicos / Antimetabolitos Antineoplásicos Límite: Humans / Male / Middle aged Idioma: En Revista: Clin Transl Med Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Adenocarcinoma / Carcinoma Ductal Pancreático / Bevacizumab / Antineoplásicos Inmunológicos / Antimetabolitos Antineoplásicos Límite: Humans / Male / Middle aged Idioma: En Revista: Clin Transl Med Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos